Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Preserving Patient Access to Physicians Act of 2005
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 2356, S 1081, HR 2218
Biodefense and Pandemic Vaccine and Drug Development Act of 2005
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3010, HR 1775, S.473/HR215, S1873
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2006 · year_end · YY
HR 3010, HR 1775, S.473/HR215, S1873
HR1175, S473/HR215, S236?HR1016, S.544, HR4568, S306
Source: Senate LDA
Biodefense and Pandemic Vaccine and Drug Development Act of 2005
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3010, HR 1775, S.473/HR215, S1873
Critical Access to Clinical Lab Services Act of 2005
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR1175, S473/HR215, S236?HR1016, S.544, HR4568, S306
Genetic Information Nondiscrimination Act of 2005
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR1175, S473/HR215, S236?HR1016, S.544, HR4568, S306
Allied Health Reinvestment Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR3010, HR 1175, S.473/HR 215, HR 2356
Allied Health Reinvestment Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3010, HR 1775, S.473/HR215, S1873
Allied Health Reinvestment Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR1175, S473/HR215, S236?HR1016, S.544, HR4568, S306
Allied Health Reinvestment Act
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR 3010, HR 1775, S.473/HR215, S1873
Patient Safety and Quality Improvement Act of 2005
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR1175, S473/HR215, S236?HR1016, S.544, HR4568, S306
To suspend temporarily the duty on Bayderm Bottom 10UD.
Client: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY · Firm: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
HR1175, S473/HR215, S236?HR1016, S.544, HR4568, S306
HR 2356, S 1081, HR 2218
HR3010, HR 1175, S.473/HR 215, HR 2356
HR 3010, HR 1775, S.473/HR215, S1873
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2006 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2004 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY via AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2004 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE